Comparison of Amnio‐Exchange With a Novel Synthetic Amniotic Fluid Versus Commercially Used Fluids for Fetal Therapy: An In Vivo Rodent Model
Prenatal Diagnosis · 2024
DOI: 10.1002/pd.6644 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Prenatal Diagnosis, 2024. Verfasst von Samuel Martin und 3 weiteren Autor:innen. Beteiligte Einrichtung: Center for Fetal and Placental Research, Cincinnati Children's Hospital Medical Center (CCHMC), Cincinnati, Ohio, USA. Hauptthemen laut MEDLINE: Amniotic Fluid, Fetal Therapies. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: North American Fetal Therapy Network.
Abstract (Originalsprache)
Objective
Normal Saline (NS) and Lactated Ringer's (LR) damage human amniotic epithelium in vitro when compared with a synthetic amniotic fluid (Amnio‐well, AW). We sought to evaluate the effect of amnio‐exchange with NS, LR, and AW in vivo.
Methods
On day E17.5, pregnant rats underwent amnio‐exchange with NS, LR, or AW. Fetuses in each pregnant rat that did not undergo amnio‐exchange acted as controls. Amnions were harvested at E20.5 and ultrastructure evaluated via electron microscopy. Protein levels of cleaved matrix metalloproteinase 9 (MMP9) and collagen 1 (Col1a) were evaluated via Western Blot. Connexin‐43 expression was evaluated via immunofluorescence (IF).
Results
There was an increase in amnion microfractures and epithelial cellular shrinkage with NS and LR compared with control and AW. The cleaved MMP9/Col1 ratio was increased 3.9‐fold in NS ( p < 0.001) and 4.5‐fold LR ( p = 0.0201) relative to control, whereas AW expression was similar to control ( p = 0.636). Connexin‐43 was also increased on IF in NS and LR relative to AW (mean gray intensity 26.5 ± 4.5, 26.5 ± 6.7, 19.2 ± 3.4, p < 0.001).
Conclusion
Amnio‐exchange with NS and LR led to increased amniotic microfractures and collagen degradation compared with synthetic amniotic fluid. Larger models are warranted to validate or refute these findings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Center for Fetal and Placental Research, Cincinnati Children's Hospital Medical Center (CCHMC), Cincinnati, Ohio, USA.
- Division of General and Thoracic, Department of Pediatric Surgery, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
- Department of Radiation Oncology, University of Cincinnati Medical Center, Cincinnati, Ohio, USA.
- Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, University of Cincinnati Medical Center, Cincinnati, Ohio, USA.
ORCID-Profile: Braxton Forde
Förderung
- North American Fetal Therapy Network
Zitieren
APA
Martin, S., Peiro, J. L., Oria, M., & Forde, B. (2024). Comparison of Amnio‐Exchange With a Novel Synthetic Amniotic Fluid Versus Commercially Used Fluids for Fetal Therapy: An In Vivo Rodent Model. Prenatal Diagnosis. https://doi.org/10.1002/pd.6644
Vancouver
Martin S, Peiro JL, Oria M, Forde B. Comparison of Amnio‐Exchange With a Novel Synthetic Amniotic Fluid Versus Commercially Used Fluids for Fetal Therapy: An In Vivo Rodent Model. Prenatal Diagnosis. 2024. doi:10.1002/pd.6644
BibTeX
@article{Martin2024,
author = {Martin, Samuel and Peiro, Jose L and Oria, Marc and Forde, Braxton},
title = {Comparison of Amnio‐Exchange With a Novel Synthetic Amniotic Fluid Versus Commercially Used Fluids for Fetal Therapy: An In Vivo Rodent Model},
journal = {Prenatal Diagnosis},
year = {2024},
doi = {10.1002/pd.6644}
}
EUVIMED